9-11 Week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Determine Effects of Adjunctive Levetiracetam on Sleep Architecture of Adults With Partial Onset Epilepsy Receiving a First Generation Anti-Epileptic Drug.

Trial Profile

9-11 Week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Determine Effects of Adjunctive Levetiracetam on Sleep Architecture of Adults With Partial Onset Epilepsy Receiving a First Generation Anti-Epileptic Drug.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Oct 2009

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Sponsors UCB Pharma Inc
  • Most Recent Events

    • 03 Jan 2008 Status changed from in progress to completed.
    • 18 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top